<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Oral composition and method for the treatment of inflammatory cutaneous disorders"><meta name="DC.contributor" content="Frank Pollard" scheme="inventor"><meta name="DC.contributor" content="Sirius Laboratories" scheme="assignee"><meta name="DC.date" content="2002-12-6" scheme="dateSubmitted"><meta name="DC.description" content="A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format."><meta name="DC.date" content="2005-12-27" scheme="issued"><meta name="DC.relation" content="US:20030147930:A1" scheme="references"><meta name="DC.relation" content="US:4505896" scheme="references"><meta name="DC.relation" content="US:4725609" scheme="references"><meta name="DC.relation" content="US:5459153" scheme="references"><meta name="DC.relation" content="US:5571441" scheme="references"><meta name="DC.relation" content="US:5759559" scheme="references"><meta name="DC.relation" content="US:5866106" scheme="references"><meta name="DC.relation" content="US:5972382" scheme="references"><meta name="DC.relation" content="US:5972985" scheme="references"><meta name="DC.relation" content="US:5972999" scheme="references"><meta name="DC.relation" content="US:5989523" scheme="references"><meta name="DC.relation" content="US:6020351" scheme="references"><meta name="DC.relation" content="US:6133317" scheme="references"><meta name="DC.relation" content="US:6177476" scheme="references"><meta name="DC.relation" content="US:6248763" scheme="references"><meta name="DC.relation" content="US:6299886" scheme="references"><meta name="DC.relation" content="US:6361800" scheme="references"><meta name="DC.relation" content="US:6403349" scheme="references"><meta name="DC.relation" content="US:6407141" scheme="references"><meta name="DC.relation" content="US:6660293" scheme="references"><meta name="citation_reference" content="Kirk-Othmer Encyclopedia of Chemical Technology, 4&lt;SUP&gt;th &lt;/SUP&gt;rd., John Wiley &amp; Sons, NY, 1993, pp. 274-300."><meta name="citation_reference" content="Remington&#39;s Pharmaceutical Sciences, Mack Publishing Co., Easton (PA), 1985, pp. 1644-1654."><meta name="citation_patent_number" content="US:6979468"><meta name="citation_patent_application_number" content="US:10/313,165"><link rel="canonical" href="http://www.google.com/patents/US6979468"/><meta property="og:url" content="http://www.google.com/patents/US6979468"/><meta name="title" content="Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous disorders"/><meta name="description" content="A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format."/><meta property="og:title" content="Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous disorders"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("S5btU-GCAuG7sASVhIDoBQ"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("ITA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("S5btU-GCAuG7sASVhIDoBQ"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("ITA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6979468?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6979468"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=lllwBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6979468&amp;usg=AFQjCNEkBTPW44G0ZtWDkahBUoRh1bgigg" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6979468.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6979468.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6979468" style="display:none"><span itemprop="description">A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered...</span><span itemprop="url">http://www.google.com/patents/US6979468?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous disorders</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous disorders" title="Patent US6979468 - Oral composition and method for the treatment of inflammatory cutaneous disorders"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6979468 B1</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 10/313,165</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Dec 27, 2005</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Dec 6, 2002</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Dec 6, 2002</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">10313165, </span><span class="patent-bibdata-value">313165, </span><span class="patent-bibdata-value">US 6979468 B1, </span><span class="patent-bibdata-value">US 6979468B1, </span><span class="patent-bibdata-value">US-B1-6979468, </span><span class="patent-bibdata-value">US6979468 B1, </span><span class="patent-bibdata-value">US6979468B1</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Frank+Pollard%22">Frank Pollard</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Sirius+Laboratories%22">Sirius Laboratories</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6979468.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6979468.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6979468.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (20),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (2),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (5),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (43),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (11)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6979468&usg=AFQjCNHSudEY4nxgefpPTuFklNZiwRMtug">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6979468&usg=AFQjCNH704KOjvrZl3rbKI5QHWhAJ1MrkA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6979468B1%26KC%3DB1%26FT%3DD&usg=AFQjCNGWLxFqBPNXeZdTQSBpflRaDROQYQ">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT55505858" lang="EN" load-source="patent-office">Oral composition and method for the treatment of inflammatory cutaneous disorders</invention-title></span><br><span class="patent-number">US 6979468 B1</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50912000" lang="EN" load-source="patent-office"> <div num="p-0001" class="abstract">A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(8)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6979468-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6979468-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(16)</span></span></div><div class="patent-text"><div mxw-id="PCLM8941044" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text">1. An oral pharmaceutical preparation in dosage unit form adapted for administration for the treatment of inflammatory skin disorders, comprising, per dosage unit, at least 250 mg of nicotinamide in an immediate release form, and an amount of zinc in a sustained release form, said amount of zinc being sufficient to provide an enhanced anti-inflammatory effect, in a vehicle pharmaceutically acceptable for oral administration.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text">2. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein said zinc is present as zinc oxide, zinc sulfate, zinc gluconate, zinc complexes or zinc chelates.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text">3. The oral pharmaceutical preparation of <claim-ref idref="CLM-00002">claim 2</claim-ref> wherein said zinc is present as zinc oxide in the amount of about at least 15 mg per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text">4. The oral pharmaceutical preparation of <claim-ref idref="CLM-00003">claim 3</claim-ref> wherein said zinc oxide is present in the amount of about at least 20 mg per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00005" num="00005" class="claim">
      <div class="claim-text">5. The oral pharmaceutical preparation of <claim-ref idref="CLM-00004">claim 4</claim-ref> wherein said zinc oxide is present in the amount of about at least 25 mg per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00006" num="00006" class="claim">
      <div class="claim-text">6. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising an amount of folic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00007" num="00007" class="claim">
      <div class="claim-text">7. The oral pharmaceutical preparation of <claim-ref idref="CLM-00006">claim 6</claim-ref> wherein said folic acid is present in the amount of at least about 500 micrograms per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00008" num="00008" class="claim">
      <div class="claim-text">8. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein said nicotinamide is present in the amount of about at least 500 mg per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00009" num="00009" class="claim">
      <div class="claim-text">9. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein said nicotinamide is present in the amount of about at least 750 mg per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00010" num="00010" class="claim">
      <div class="claim-text">10. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising an amount of a copper-containing compound.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00011" num="00011" class="claim">
      <div class="claim-text">11. The oral pharmaceutical preparation of <claim-ref idref="CLM-00010">claim 10</claim-ref> wherein said copper-containing compound is in an immediate release form.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00012" num="00012" class="claim">
      <div class="claim-text">12. The oral pharmaceutical preparation of <claim-ref idref="CLM-00010">claim 10</claim-ref> wherein said copper-containing compound is selected from the group consisting of cupric oxide, cupric sulfate, copper complexes and copper chelates.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00013" num="00013" class="claim">
      <div class="claim-text">13. The oral pharmaceutical preparation of <claim-ref idref="CLM-00010">claim 10</claim-ref> wherein said copper-containing compound is present in an amount of about at least 1.0 milligrams per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00014" num="00014" class="claim">
      <div class="claim-text">14. The oral pharmaceutical preparation of <claim-ref idref="CLM-00013">claim 13</claim-ref> wherein said copper-containing compound is present in an amount of about at least 1.5 milligrams per dosage unit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00015" num="00015" class="claim">
      <div class="claim-text">15. The oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein each dosage unit is in the form of a tablet, capsule or softgel.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00016" num="00016" class="claim">
      <div class="claim-text">16. A method for the treatment of inflammatory skin conditions, the method comprising the step of orally administering to a person having said inflammatory skin condition the oral pharmaceutical preparation of <claim-ref idref="CLM-00001">claim 1</claim-ref>.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES15963588" lang="EN" load-source="patent-office" class="description">
    <heading>BACKGROUND OF THE INVENTION</heading> <p num="p-0002">This invention relates to the use of a unique oral preparation for the treatment of inflammatory skin conditions. More particularly, this invention relates to a composition and method for the treatment of inflammatory skin conditions such as acne rosacea and acne vulgaris comprising an immediate release form of nicotinamide in combination with a sustained release form of zinc combined complementary other active ingredients to provide optimum levels of several different treatment modalities. The combination of an immediate release nicotinamide and sustained release zinc provides an unexpected synergistic anti-inflammatory effect that is not observed with combinations of immediate release forms of both chemicals.</p>
    <p num="p-0003">Acne vulgaris is an inflammatory disease of the pilosebaceous glands characterized by an eruption of the skin, often pustular in nature but not suppurative. Acne is a common affliction of the adolescent and affects a small but significant percentage of the adult population. Acne lesions are of four basic types: comedones (blackheads or whiteheads), papules, pustules, and cysts (or nodules). Various topical agents are utilized in the treatment of acne and these include sulfur, resorcinol, salicylic acid, benzoyl peroxide, vitamin A acid and topical antibiotics. Other treatment methods include topically applying various scrubbing or abrasive compositions, topically applying deep cleaning or astringent compositions, and also exposure to ultraviolet radiation. Acne involvement can result in unsightly lesions, particularly on the face, and in some cases in severe scarring.</p>
    <p num="p-0004">Acne rosacea is another inflammatory skin affliction characterized by erythema with or without an acneiform component (papules, pustules, or nodules). Rosacea typically occurs in adults of about 30–50 years of age. The acneiform component or rosacea has been treated in the past in a fashion similar to the treatment for acne vulgaris. Systemic antibiotics have also been helpful.</p>
    <p num="p-0005">Nicotinamide and nicotinic acid are water soluble vitamins whose physiologically active forms include nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). Nicotinamide and nicotinic acid have been used routinely to treat pellegra for which they are therapeutic. Nicotinamide is available from a variety of pharmaceutical houses such as Roche Vitamin, Inc., of Nutley, N.J.; Armor Pharmaceutical Company located in Phoenix Ariz.; Brown Pharmaceutical Company Inc. located in Los Angeles, Calif.; and Keith Pharmaceutical Inc. located in Miami, Fla.</p>
    <p num="p-0006">It is known that a high dose of immediate release nicotinamide will have greater bioavailability and greater extended activity than that of a sustained release application.</p>
    <p num="p-0007">U.S. Pat. No. 4,505,896 teaches the use of oral compositions containing nicotinamide in the treatment of acne vulgaris. The nicotinamide is administered orally in doses of 100–600 milligrams per day in divided doses taken 2 to 4 times per day. The treatment was reported to decrease inflammatory lesions such as papules, pustules, and cysts, but not comedones.</p>
    <p num="p-0008">U.S. Pat. No. 4,725,609 teaches the topical application of nicotinamide to promote angiogenesis, reepithelialization and wound healing.</p>
    <p num="p-0009">U.S. Pat. No. 5,459,153 teaches a method for treatment of acne vulgaris comprising administration to a patient of a mixture of pantothenic acid, nicotinic acid, and biotin, to generate nicotinamide in vivo.</p>
    <p num="p-0010">U.S. Pat. No. 5,989,523 teaches a topical spray of 1–10% niacinamide with a humectant to treat acne.</p>
    <p num="p-0011">U.S. Pat. No. 6,020,351 teaches selectively administering a daily dosage of carotenoids, nicotinamide, and a source of zinc, in excess of normal dietary levels for improving resistance to DNA damage, enhancing DNA repair capacity, and stimulating immune function.</p>
    <p num="p-0012">U.S. Pat. No. 6,248,763 teaches the topical application of nicotinamide to treat acne.</p>
    <p num="p-0013">It has been reported in the medical literature that acne is often associated with low zinc levels in blood serum and in the epidermal layer. The therapeutic effect of zinc as an anti-inflammatory agent has been well documented, and oral zinc has been reported to be helpful in the treatment of certain types of acne. It is also known that zinc supplementation should be used with copper supplementation to avoid a copper deficiency that might otherwise occur.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p num="p-0014">The present invention provides an improved method and composition for the treatment of acne vulgaris, acne rosacea, bullous pemphigoid and other inflammatory skin conditions. The invention relates to the oral administration of a composition comprising a large dose of nicotinamide delivered at levels very substantially in excess of normal dietary levels, the nicotinamide being delivered in immediate release form in combination with a dose of zinc provided in a sustained release form. This combination of immediate release nicotinamide and sustained release zinc provides a level of anti-inflammatory activity substantially exceeding that provided by combinations of immediate release forms of nicotinamide and zinc. The sustained release form of zinc also permits the unopposed absorption of orally administered tetracycline and its cogeners, which are frequently utilized as a part of the treatment regimens for acne vulgaris, acne rosacea and certain other inflammatory cutaneous disorders. In one preferred embodiment of the invention, a quantity of copper is included to avoid the copper deficiency that might otherwise occur due to the zinc supplementation. The composition may also include a quantity of folic acid, which is an essential nutrient in teenagers and women of child-bearing age.</p>
    <p num="p-0015">In a most preferred embodiment, nicotinamide and copper and folic acid each are present in immediate release forms, while the zinc is present in a sustained release form. This reduces the interaction between zinc and copper that can reduce the absorption of both. It also reduces the side effects such as nausea that might otherwise be associated with high levels of orally administered zinc</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p num="p-0016">The oral composition of the present invention comprises an amount of an immediate release form of nicotinamide very substantially greater than that obtained through the normal diet, combined with a sustained release form of zinc, both delivered in sufficient quantities to provide a therapeutic effect over an extended period for acne vulgaris, acne rosacea, bullous pemphigoid or other inflammatory skin conditions. For purpose of this patent, an immediate release form is one that releases 75% of the active ingredient within two hours of ingestion. A high dose of immediate release nicotinamide increases the bioavailablity of nicotinamide and extends the activity of nicotinamide over that of a sustained release formulation. This unexpected event is unique to oral nicotinamide. The nicotinamide will be present in an amount of at least 250 mg per dose, more preferably at least about 500 mg per dose, and most preferably at least about 750 mg per dose.</p>
    <p num="p-0017">In compositions of the present invention, the sustained release form of zinc will be present in an amount sufficient to provide an anti-inflammatory effect. The zinc may be present in any pharmaceutically acceptable zinc salt, zinc complex or zinc chelate for oral administration. Zinc oxide is one such preferred zinc salt. However, other zinc salts such as zinc sulfate and zinc gluconate, zinc complexes or zinc chelates may be substituted, in the sustained release form for the zinc oxide. Zinc oxide can be present in an amount of about at least about 15 mg per dose, more preferably at least about 20 mg per dose, and most preferably at least about 25 mg per doseCompositions within the scope of the present invention may also include a copper-containing compound. Such a copper-containing compound can be any copper compound or copper salt known to be suitable for oral ingestion for copper supplementation, such as cupric oxide or copper salts including cupric sulfate, as well as copper complexes or chelates, but is preferably in an immediate release format. The copper-containing compound should be present in an amount sufficient to compensate for any copper deficiency that might otherwise occur due to the increased levels of zinc. The copper can be present in an amount of about at least 1.0 milligrams per dose, and more preferably in an amount of about at least 1.5 milligrams per dose, regardless of the form of the copper compound used.</p>
    <p num="p-0018">The compositions of the present invention may also include a quantity of folic acid. Folic acid is an essential nutrient for a developing fetus. The diets of many teens and young adults are deficient in folic acid. It is expected that the subject invention will be used primarily by teens and young adults who suffer from acne vulgaris. The use of folic acid in compositions of the present invention is intended to supplement this essential nutrient in this segment of the population. The folic acid can be present in the amount of about at least 500 micrograms.</p>
    <heading>EXAMPLE 1</heading> <p num="p-0019">A composition is prepared in tablet form, each tablet comprising 750 milligrams immediate release nicotinamide, 25 milligrams sustained release zinc oxide, and 500 micrograms immediate release folic acid. When administered orally twice daily, the tablets are found to be a highly effective treatment for acne vulgaris.</p>
    <heading>EXAMPLE 2</heading> <p num="p-0020">A composition is prepared in tablet form each tablet comprising 750 milligrams immediate release nicotinamide, 25 milligrams sustained release zinc oxide, 500 micrograms immediate release folic acid, and 1.5 milligrams immediate release copper sulfate. When administered orally twice daily, the tablets are found to be a highly effective treatment for acne vulgaris.</p>
    <heading>EXAMPLE 3</heading> <p num="p-0021">A composition is prepared in tablet form each tablet comprising 1000 milligrams immediate release nicotinamide, 15 milligrams sustained release zinc oxide, 500 micrograms immediate release folic acid, and 1.0 milligrams immediate release copper sulfate. When administered orally twice daily, the tablets are found to be a highly effective treatment for acne vulgaris.</p>
    <heading>EXAMPLE 4</heading> <p num="p-0022">A composition is prepared in tablet form each tablet comprising 500 milligrams immediate release nicotinamide, 30 milligrams sustained release zinc oxide, 500 micrograms immediate release folic acid, and 1.5 milligrams immediate release copper sulfate. When administered orally twice daily, the tablets are found to be a highly effective treatment for acne vulgaris.</p>
    <heading>EXAMPLE 5</heading> <p num="p-0023">A composition is prepared in tablet form each tablet comprising 650 milligrams immediate release nicotinamide, 30 milligrams sustained release zinc oxide, 500 micrograms immediate release folic acid, and 1.5 milligrams immediate release copper sulfate. When administered orally twice daily, the tablets are found to be a highly effective treatment for acne vulgaris.</p>
    <p num="p-0024">It is to be understood that the invention is not limited to the features and embodiments hereinabove set forth, but may be carried out in other ways without departing from it s spirit.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4505896">US4505896</a></td><td class="patent-data-table-td patent-date-value">Nov 24, 1980</td><td class="patent-data-table-td patent-date-value">Mar 19, 1985</td><td class="patent-data-table-td ">Elorac, Ltd.</td><td class="patent-data-table-td ">Method of treating acne vulgaris and composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4725609">US4725609</a></td><td class="patent-data-table-td patent-date-value">Nov 20, 1984</td><td class="patent-data-table-td patent-date-value">Feb 16, 1988</td><td class="patent-data-table-td ">Burroughs Wellcome Co.</td><td class="patent-data-table-td ">Method of promoting healing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5459153">US5459153</a></td><td class="patent-data-table-td patent-date-value">Sep 10, 1990</td><td class="patent-data-table-td patent-date-value">Oct 17, 1995</td><td class="patent-data-table-td ">Leung; Lit-Hung</td><td class="patent-data-table-td ">Composition and methods for treatment of acne vulgaris and for retardation of aging</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5571441">US5571441</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 1, 1994</td><td class="patent-data-table-td patent-date-value">Nov 5, 1996</td><td class="patent-data-table-td ">The Procter &amp; Gamble Company</td><td class="patent-data-table-td ">Nutrient supplement compositions providing physiologic feedback</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5759559">US5759559</a></td><td class="patent-data-table-td patent-date-value">May 5, 1997</td><td class="patent-data-table-td patent-date-value">Jun 2, 1998</td><td class="patent-data-table-td ">Fitzjarrell; Edwin A.</td><td class="patent-data-table-td ">Niacinamide, carrier, zinc or chromium picolinate used after cleaning acne area then spraying with solution and taking oral dosage</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5866106">US5866106</a></td><td class="patent-data-table-td patent-date-value">Feb 3, 1997</td><td class="patent-data-table-td patent-date-value">Feb 2, 1999</td><td class="patent-data-table-td ">Pacer Technology</td><td class="patent-data-table-td ">Vitamin/mineral-enriched cyanoacrylate cosmetic</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5972382">US5972382</a></td><td class="patent-data-table-td patent-date-value">Jan 12, 1998</td><td class="patent-data-table-td patent-date-value">Oct 26, 1999</td><td class="patent-data-table-td ">Sabinsa Corporation</td><td class="patent-data-table-td ">Use of piperine as a bioavailability enhancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5972985">US5972985</a></td><td class="patent-data-table-td patent-date-value">Nov 3, 1997</td><td class="patent-data-table-td patent-date-value">Oct 26, 1999</td><td class="patent-data-table-td ">Cytos Pharmaceuticals, Llc</td><td class="patent-data-table-td ">Histidine containing nutriceutical compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5972999">US5972999</a></td><td class="patent-data-table-td patent-date-value">Sep 3, 1998</td><td class="patent-data-table-td patent-date-value">Oct 26, 1999</td><td class="patent-data-table-td ">Murad; Howard</td><td class="patent-data-table-td ">Pharmaceutical compositions and methods for improving wrinkles and other skin conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5989523">US5989523</a></td><td class="patent-data-table-td patent-date-value">Mar 20, 1998</td><td class="patent-data-table-td patent-date-value">Nov 23, 1999</td><td class="patent-data-table-td ">Fitzjarrell; Edwin A.</td><td class="patent-data-table-td ">Topical spray for treating acne containing niacinamide and NaPCA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6020351">US6020351</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 1996</td><td class="patent-data-table-td patent-date-value">Feb 1, 2000</td><td class="patent-data-table-td ">Oxigene, Inc.</td><td class="patent-data-table-td ">Carotenoid-nicotinamide-zinc compositions and methods of treatment using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6133317">US6133317</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1996</td><td class="patent-data-table-td patent-date-value">Oct 17, 2000</td><td class="patent-data-table-td ">Hart; Francis J.</td><td class="patent-data-table-td ">For treating at least one of tumors, brain tumors, cancers, and growths in warm blooded animals such as humans or pets; composition is adapted to be administered in less than a lethal dosage; adding to pet food; pills, gelcaps</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6177476">US6177476</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 27, 1998</td><td class="patent-data-table-td patent-date-value">Jan 23, 2001</td><td class="patent-data-table-td ">Clarion Pharmaceuticals Inc.</td><td class="patent-data-table-td ">Administering a glycerol ether compound</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6248763">US6248763</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 1999</td><td class="patent-data-table-td patent-date-value">Jun 19, 2001</td><td class="patent-data-table-td ">Scivoletto Rosemarie</td><td class="patent-data-table-td ">Psoriasis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6299886">US6299886</a></td><td class="patent-data-table-td patent-date-value">Jul 17, 1998</td><td class="patent-data-table-td patent-date-value">Oct 9, 2001</td><td class="patent-data-table-td ">Edwina M Piper</td><td class="patent-data-table-td ">Treating allergy comprising administering formulation comprising potassium gluconate, magnesium oxide, pyridoxine hydrochloride, pantothenic acid, ascorbic acid and an n-3 or n-6 essential fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6361800">US6361800</a></td><td class="patent-data-table-td patent-date-value">Apr 13, 2000</td><td class="patent-data-table-td patent-date-value">Mar 26, 2002</td><td class="patent-data-table-td ">Cooper Concepts, Inc.</td><td class="patent-data-table-td ">Vitamin and mineral supplements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6403349">US6403349</a></td><td class="patent-data-table-td patent-date-value">Sep 2, 1998</td><td class="patent-data-table-td patent-date-value">Jun 11, 2002</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6407141">US6407141</a></td><td class="patent-data-table-td patent-date-value">Mar 27, 2000</td><td class="patent-data-table-td patent-date-value">Jun 18, 2002</td><td class="patent-data-table-td ">Francis J. Hart</td><td class="patent-data-table-td ">Arteriosclerosis, atherosclerosis, endocarditis, fatty buildup, and microbial infections; cardiovascular disorders; hemotherapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6660293">US6660293</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 19, 2001</td><td class="patent-data-table-td patent-date-value">Dec 9, 2003</td><td class="patent-data-table-td ">Everett Laboratories, Inc.</td><td class="patent-data-table-td ">Carotenoids; vitamins E, D, &amp; C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030147930">US20030147930</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 9, 2002</td><td class="patent-data-table-td patent-date-value">Aug 7, 2003</td><td class="patent-data-table-td ">Hong-Ki Jun</td><td class="patent-data-table-td ">Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kirk-Othmer Encyclopedia of Chemical Technology, 4&lt;SUP&gt;th &lt;/SUP&gt;rd., John Wiley &amp; Sons, NY, 1993, pp. 274-300.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Remington's Pharmaceutical Sciences, Mack Publishing Co., Easton (PA), 1985, pp. 1644-1654.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7256184">US7256184</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 1, 2004</td><td class="patent-data-table-td patent-date-value">Aug 14, 2007</td><td class="patent-data-table-td ">Rodriguez Victorio C</td><td class="patent-data-table-td ">analyzing concentration of carbonic anhydrase isozymes in tissues, blood or cerebrospinal fluid of patients, than administering proenzymes or drugs that promotes the natural generation of the cell-specific carbonic anhydrase enzymes; aging resistance</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7439390">US7439390</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 14, 2005</td><td class="patent-data-table-td patent-date-value">Oct 21, 2008</td><td class="patent-data-table-td ">Degussa Ag</td><td class="patent-data-table-td ">Reacting aldehyde with amide, carbon monoxide and hydrogen in amidocarbonylation reaction to give N-acyl amino acid in presence of cobalt carbonyl catalyst, precipitating Co(N-acyl-amino acid)2 by feeding oxygen into mixture, separating Co(N-acyl-amino acid)2, hydrolyzing residue to obtain amino acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7572937">US7572937</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 14, 2005</td><td class="patent-data-table-td patent-date-value">Aug 11, 2009</td><td class="patent-data-table-td ">Evonik Degussa Gmbh</td><td class="patent-data-table-td ">Process for preparing amino acids using amidocarbonylation reaction</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7687650">US7687650</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 29, 2006</td><td class="patent-data-table-td patent-date-value">Mar 30, 2010</td><td class="patent-data-table-td ">Jr Chem, Llc</td><td class="patent-data-table-td ">Copper-zinc malonates; dermatology</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7897800">US7897800</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 29, 2007</td><td class="patent-data-table-td patent-date-value">Mar 1, 2011</td><td class="patent-data-table-td ">Jr Chem, Llc</td><td class="patent-data-table-td ">Chemical compositions and methods of making them</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S643000">424/643</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S861000">514/861</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S864000">514/864</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S886000">514/886</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S355000">514/355</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S635000">424/635</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S630000">424/630</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S887000">514/887</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S249000">514/249</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S637000">424/637</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S046000">514/46</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S499000">514/499</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S964000">514/964</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S638000">424/638</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S468000">424/468</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S641000">424/641</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S865000">514/865</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S859000">514/859</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S863000">514/863</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S458000">424/458</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S400000">424/400</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S047000">514/47</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031315000">A61K31/315</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0033340000">A61K33/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0017100000">A61P17/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0033300000">A61K33/30</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031455000">A61K31/455</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/861">Y10S514/861</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/864">Y10S514/864</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/887">Y10S514/887</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/863">Y10S514/863</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/964">Y10S514/964</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/886">Y10S514/886</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/865">Y10S514/865</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/859">Y10S514/859</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/315">A61K31/315</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K33/34">A61K33/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/455">A61K31/455</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lllwBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K33/30">A61K33/30</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K31/455</span>, <span class="nested-value">A61K33/30</span>, <span class="nested-value">A61K31/315</span>, <span class="nested-value">A61K33/34</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Sep 19, 2013</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS ADMINI</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNORS:ALORA PHARMACEUTICALS, LLC;ACELLA HOLDINGS, LLC;ACELLA PHARMACEUTICALS, LLC;AND OTHERS;REEL/FRAME:031246/0359</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20130913</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 18, 2013</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20130916</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">NEUVOSYN LABORATORIES, LLC, GEORGIA</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ALORA PHARMACEUTICALS, LLC, GEORGIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">RELEASE BY SECURED PARTY;ASSIGNOR:WHITEHORSE FINANCE WAREHOUSE, LLC;REEL/FRAME:031230/0275</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVION PHARMACEUTICALS, LLC, GEORGIA</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ACELLA PHARMACEUTICALS, LLC, GEORGIA</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 20, 2013</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 11, 2012</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120831</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">WHITEHORSE FINANCE WAREHOUSE, LLC, FLORIDA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYSIDE FINANCE, LLC;REEL/FRAME:029114/0739</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 30, 2011</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYSIDE FINANCE, LLC, FLORIDA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNORS:ACELLA PHARMACEUTICALS, LLC;NEUVOSYN LABORATORIS, LLC;AVION PHARMACEUTICALS, LLC;AND OTHERS;REEL/FRAME:027464/0862</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20111230</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 31, 2011</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DUSA PHARMACEUTICALS, INC.;REEL/FRAME:026676/0901</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20110630</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ACELLA PHARMACEUTICALS, LLC, GEORGIA</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 19, 2010</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-16 ARE CANCELLED. NEW CLAIMS 17-24 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 17, 2009</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20090819</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 18, 2009</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 21, 2006</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">DUSA PHARMACEUTICALS, INC., MASSACHUSETTS</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:SIRIUS LABORATORIES, INC.;REEL/FRAME:017336/0786</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20060227</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 6, 2002</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">SIRIUS LABORATORIES, ILLINOIS</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:POLLARD, FRANK;REEL/FRAME:013556/0479</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20021205</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U2H1dmgrjVMvgfv2iyhlXm8gSQS8w\u0026id=lllwBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2Wpb-AhZvpUFyh5-r7GsxS5Pm13Q\u0026id=lllwBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1d1r_UgzJK2DGNIAk2QDTKGxnd8Q","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Oral_composition_and_method_for_the_trea.pdf?id=lllwBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3nShE_-YPPqJbaYHNf7ujPX6EN9g"},"sample_url":"http://www.google.com/patents/reader?id=lllwBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>